IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v8y2017i1d10.1038_s41467-017-00888-8.html
   My bibliography  Save this article

Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer

Author

Listed:
  • Shreya Mitra

    (University of Texas M.D. Anderson Cancer Center)

  • Jeffrey E. Montgomery

    (The University of Chicago
    Institute for Genomics and Systems Biology, The University of Chicago)

  • Matthew J. Kolar

    (Harvard University
    Harvard University)

  • Gang Li

    (The University of Chicago
    Institute for Genomics and Systems Biology, The University of Chicago)

  • Kang J. Jeong

    (University of Texas M.D. Anderson Cancer Center)

  • Bo Peng

    (University of Texas M.D. Anderson Cancer Center)

  • Gregory L. Verdine

    (Harvard University
    Harvard University)

  • Gordon B. Mills

    (University of Texas M.D. Anderson Cancer Center)

  • Raymond E. Moellering

    (The University of Chicago
    Institute for Genomics and Systems Biology, The University of Chicago)

Abstract

Recent evidence has established a role for the small GTPase RAB25, as well as related effector proteins, in enacting both pro-oncogenic and anti-oncogenic phenotypes in specific cellular contexts. Here we report the development of all-hydrocarbon stabilized peptides derived from the RAB-binding FIP-family of proteins to target RAB25. Relative to unmodified peptides, optimized stapled peptides exhibit increased structural stability, binding affinity, cell permeability, and inhibition of RAB25:FIP complex formation. Treatment of cancer cell lines in which RAB25 is pro-oncogenic with an optimized stapled peptide, RFP14, inhibits migration, and proliferation in a RAB25-dependent manner. In contrast, RFP14 treatment augments these phenotypes in breast cancer cells in which RAB25 is tumor suppressive. Transcriptional profiling identified significantly altered transcripts in response to RAB25 expression, and treatment with RFP14 opposes this expression profile. These data validate the first cell-active chemical probes targeting RAB-family proteins and support the role of RAB25 in regulating context-specific oncogenic phenotypes.

Suggested Citation

  • Shreya Mitra & Jeffrey E. Montgomery & Matthew J. Kolar & Gang Li & Kang J. Jeong & Bo Peng & Gregory L. Verdine & Gordon B. Mills & Raymond E. Moellering, 2017. "Stapled peptide inhibitors of RAB25 target context-specific phenotypes in cancer," Nature Communications, Nature, vol. 8(1), pages 1-11, December.
  • Handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00888-8
    DOI: 10.1038/s41467-017-00888-8
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/s41467-017-00888-8
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/s41467-017-00888-8?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Ammu Prasanna Kumar & Suryani Lukman, 2018. "Allosteric binding sites in Rab11 for potential drug candidates," PLOS ONE, Public Library of Science, vol. 13(6), pages 1-46, June.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:8:y:2017:i:1:d:10.1038_s41467-017-00888-8. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.